Fineberg SE - Search Results

1

Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial.

Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, Lyden PD, Broderick JP, Kwiatkowski TG, Fineberg SE; NINDS rt-PA Stroke Study Group. Bruno A, et al. Among authors: fineberg se. Neurology. 2002 Sep 10;59(5):669-74. doi: 10.1212/wnl.59.5.669. Neurology. 2002. PMID: 12221155

2

Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke.

Williams LS, Rotich J, Qi R, Fineberg N, Espay A, Bruno A, Fineberg SE, Tierney WR. Williams LS, et al. Among authors: fineberg se. Neurology. 2002 Jul 9;59(1):67-71. doi: 10.1212/wnl.59.1.67. Neurology. 2002. PMID: 12105309

3

Immunological responses to exogenous insulin.

Fineberg SE, Kawabata TT, Finco-Kent D, Fountaine RJ, Finch GL, Krasner AS. Fineberg SE, et al. Endocr Rev. 2007 Oct;28(6):625-52. doi: 10.1210/er.2007-0002. Epub 2007 Sep 4. Endocr Rev. 2007. PMID: 17785428 Review.

4

Animal versus plant protein meals in individuals with type 2 diabetes and microalbuminuria: effects on renal, glycemic, and lipid parameters.

Wheeler ML, Fineberg SE, Fineberg NS, Gibson RG, Hackward LL. Wheeler ML, et al. Among authors: fineberg se. Diabetes Care. 2002 Aug;25(8):1277-82. doi: 10.2337/diacare.25.8.1277. Diabetes Care. 2002. PMID: 12145221 Clinical Trial.

5

Salt sensitivity, pulse pressure, and death in normal and hypertensive humans.

Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M. Weinberger MH, et al. Among authors: fineberg ns, fineberg se. Hypertension. 2001 Feb;37(2 Pt 2):429-32. doi: 10.1161/01.hyp.37.2.429. Hypertension. 2001. PMID: 11230313

6

The influence of blood pressure and carbohydrate tolerance on vascular compliance in humans.

Weinberger MH, Fineberg NS, Fineberg SE. Weinberger MH, et al. Among authors: fineberg se. Am J Hypertens. 2002 Aug;15(8):678-82. doi: 10.1016/s0895-7061(02)02955-2. Am J Hypertens. 2002. PMID: 12160189

7

Antibody response to inhaled insulin in patients with type 1 or type 2 diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-year extension trial.

Fineberg SE, Kawabata T, Finco-Kent D, Liu C, Krasner A. Fineberg SE, et al. J Clin Endocrinol Metab. 2005 Jun;90(6):3287-94. doi: 10.1210/jc.2004-2229. Epub 2005 Mar 1. J Clin Endocrinol Metab. 2005. PMID: 15741258

8

Effect of long-term exposure to insulin lispro on the induction of antibody response in patients with type 1 or type 2 diabetes.

Fineberg SE, Huang J, Brunelle R, Gulliya KS, Anderson JH Jr. Fineberg SE, et al. Diabetes Care. 2003 Jan;26(1):89-96. doi: 10.2337/diacare.26.1.89. Diabetes Care. 2003. PMID: 12502663 Clinical Trial.

9

Use of an automated device for alternative site blood glucose monitoring.

Fineberg SE, Bergenstal RM, Bernstein RM, Laffel LM, Schwartz SL. Fineberg SE, et al. Diabetes Care. 2001 Jul;24(7):1217-20. doi: 10.2337/diacare.24.7.1217. Diabetes Care. 2001. PMID: 11423505

10

Glycaemic control and hormone replacement therapy: implications of the Postmenopausal Estrogen/Progestogen Intervention (PEPI) study.

Fineberg SE. Fineberg SE. Drugs Aging. 2000 Dec;17(6):453-61. doi: 10.2165/00002512-200017060-00003. Drugs Aging. 2000. PMID: 11200306 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page